Lioresal in the treatment of spinal spasticity.
D000328:Adult; D000613:Aminobutyrates / Q000009:adverse effects / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D009128:Muscle Spasticity / Q000188:drug therapy*; D010264:Paraplegia / Q000188:drug therapy; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D011782:Quadriplegia / Q000188:drug therapy; D013118:Spinal Cord Diseases / Q000188:drug therapy*
D000613:Aminobutyrates; D002722:Chlorobenzenes; D010276:Parasympatholytics